Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Clinical and Translational Radiation Oncology
|
January 7, 2025
Corrigendum to "Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery" [Clin. Transl. Radiat. Oncol. 43 (2023) 100678]
Erin M McClure, Geoffrey Sedor, Yuxuan Jin, et al.
Clinical and Translational Radiation Oncology
|
October 2, 2023
Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery
Erin M McClure, Geoffrey Sedor, Yuxuan Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Letter Response
Geoffrey Sedor, Jacob G Scott, Michael W Kattan, et al.
Advances in Radiation Oncology
|
January 8, 2025
Image Guidance is Associated with Improved Freedom From Recurrence After Superficial Radiation Therapy for Nonmelanoma Skin Cancer
Erin M McClure, Geoffrey Sedor, Mairead Moloney, et al.
The Lancet. Oncology
|
November 4, 2021
Radiotherapy with genomic-adjusted radiation dose - Authors' reply
Jacob G Scott, Geoffrey Sedor, Jessica A Scarborough, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2021
Response to: Noncancer Cells in Tumor Samples May Bias the Predictive Genomically Adjusted Radiation Dose
G Daniel Grass, Jacob G Scott, Geoffrey Sedor, et al.
The Lancet. Oncology
|
August 7, 2021
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis
Jacob G Scott, Geoffrey Sedor, Patrick Ellsworth, et al.
American Journal of Clinical Oncology
|
April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study
Shireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
American Journal of Clinical Oncology
|
January 6, 2021
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma
Shireen Parsai, Geoffrey Sedor, Timothy D Smile, et al.
Clinical and Translational Radiation Oncology
|
August 16, 2024
CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience
Albert Lee, Jared Pasetsky, Elizaveta Lavrova, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Clinical and Translational Radiation Oncology
|
January 7, 2025
Corrigendum to "Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery" [Clin. Transl. Radiat. Oncol. 43 (2023) 100678]
Erin M McClure, Geoffrey Sedor, Yuxuan Jin, et al.
Clinical and Translational Radiation Oncology
|
October 2, 2023
Image-guided superficial radiation therapy has superior 2-year recurrence probability to Mohs micrographic surgery
Erin M McClure, Geoffrey Sedor, Yuxuan Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Letter Response
Geoffrey Sedor, Jacob G Scott, Michael W Kattan, et al.
Advances in Radiation Oncology
|
January 8, 2025
Image Guidance is Associated with Improved Freedom From Recurrence After Superficial Radiation Therapy for Nonmelanoma Skin Cancer
Erin M McClure, Geoffrey Sedor, Mairead Moloney, et al.
The Lancet. Oncology
|
November 4, 2021
Radiotherapy with genomic-adjusted radiation dose - Authors' reply
Jacob G Scott, Geoffrey Sedor, Jessica A Scarborough, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2021
Response to: Noncancer Cells in Tumor Samples May Bias the Predictive Genomically Adjusted Radiation Dose
G Daniel Grass, Jacob G Scott, Geoffrey Sedor, et al.
The Lancet. Oncology
|
August 7, 2021
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis
Jacob G Scott, Geoffrey Sedor, Patrick Ellsworth, et al.
American Journal of Clinical Oncology
|
April 30, 2020
Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study
Shireen Parsai, Aditya Juloori, Geoffrey Sedor, et al.
American Journal of Clinical Oncology
|
January 6, 2021
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma
Shireen Parsai, Geoffrey Sedor, Timothy D Smile, et al.
Clinical and Translational Radiation Oncology
|
August 16, 2024
CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience
Albert Lee, Jared Pasetsky, Elizaveta Lavrova, et al.
Page
of 2